Related references
Note: Only part of the references are listed.3-D localization of non-radioactive strontium in osteoarthritic bone: Role in the dynamic labeling of bone pathological changes
Arash Panahifar et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2015)
Treating osteoporosis by targeting parathyroid hormone to bone
T. Ponnapakkam et al.
DRUG DISCOVERY TODAY (2014)
Synthesis, Characterization and Biodistribution Studies of 125I-Radioiodinated di-PEGylated Bone Targeting Salmon Calcitonin Analogue in Healthy Rats
Yang Yang et al.
PHARMACEUTICAL RESEARCH (2014)
Bifunctional bisphosphonates for delivering PTH (1-34) to bone mineral with enhanced bioactivity
Jivan N. Yewle et al.
BIOMATERIALS (2013)
Compositional and Material Properties of Rat Bone after Bisphosphonate and/or Strontium Ranelate Drug Treatment
Yuchin Wu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2013)
Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats
Krishna Hari Bhandari et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation
A. Panahifar et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration
Georges Boivin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Phosphine-mediated one-pot thiol-ene click'' approach to polymer-protein conjugates
Mathew W. Jones et al.
CHEMICAL COMMUNICATIONS (2009)
Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate
Sinead M. Ryan et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Improved Bone Delivery of Osteoprotegerin by Bisphosphonate Conjugation in a Rat Model of Osteoarthritis
Michael R. Doschak et al.
MOLECULAR PHARMACEUTICS (2009)
Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT
J. E. M. Brouwers et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Teriparatide A Review of its Use in Osteoporosis
Stephanie K. A. Blick et al.
DRUGS (2008)
Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats
Yuki Washimi et al.
BONE (2007)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey
Karen O. Jones et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Three-point bending of rat femur in the mediolateral direction:: Introduction and validation of a novel biomechanical testing protocol
Olli Leppanen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss
JI Aguirre et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
LG Raisz
JOURNAL OF CLINICAL INVESTIGATION (2005)
Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone
D Farlay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomnized rats
A Valenta et al.
BONE (2005)
Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands
TM Murray et al.
ENDOCRINE REVIEWS (2005)
Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
DH Na et al.
ANALYTICAL BIOCHEMISTRY (2004)
Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats
P Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
C Deal et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2003)
Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
JR Zanchetta et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety
JL Vahle et al.
TOXICOLOGIC PATHOLOGY (2002)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors
SRJ Hoare et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion
V Shen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
